|
| | HB3799 Engrossed | | LRB104 11270 BAB 21355 b |
|
|
| 1 | | AN ACT concerning regulation. |
| 2 | | Be it enacted by the People of the State of Illinois, |
| 3 | | represented in the General Assembly: |
| 4 | | Section 5. The Illinois Insurance Code is amended by |
| 5 | | changing Sections 132, 132.3, 143.15, and 143.17 and by adding |
| 6 | | Article XLVIII as follows: |
| 7 | | (215 ILCS 5/132) (from Ch. 73, par. 744) |
| 8 | | Sec. 132. Market conduct actions and market analysis. |
| 9 | | (a) Definitions. As used in this Section: |
| 10 | | "Data call" means a written solicitation by the Director |
| 11 | | to 2 or more regulated companies or persons seeking existing |
| 12 | | data or other existing information to be provided within a |
| 13 | | reasonable time period for a narrow and targeted regulatory |
| 14 | | oversight purpose for market analysis. "Data call" does not |
| 15 | | include an information request in a market conduct action or |
| 16 | | any data or information that the Director shall or may |
| 17 | | specifically require under any other law, except as provided |
| 18 | | by the other law. |
| 19 | | "Desk examination" means an examination that is conducted |
| 20 | | by market conduct surveillance personnel at a location other |
| 21 | | than the regulated company's or person's premises. "Desk |
| 22 | | examination" includes an examination performed at the |
| 23 | | Department's offices with the company or person providing |
|
| | HB3799 Engrossed | - 2 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | requested documents by hard copy, microfiche, or discs or |
| 2 | | other electronic media for review without an on-site |
| 3 | | examination. |
| 4 | | "Market analysis" means a process whereby market conduct |
| 5 | | surveillance personnel collect and analyze information from |
| 6 | | filed schedules, surveys, required reports, data calls, and |
| 7 | | other sources to develop a baseline understanding of the |
| 8 | | marketplace and to identify patterns or practices of regulated |
| 9 | | persons that deviate significantly from the norm or that may |
| 10 | | pose a potential risk to insurance consumers. |
| 11 | | "Market conduct action" means any activity, other than |
| 12 | | market analysis, that the Director may initiate to assess and |
| 13 | | address the market and nonfinancial practices of regulated |
| 14 | | persons, including market conduct examinations. The |
| 15 | | Department's consumer complaint process outlined in 50 Ill. |
| 16 | | Adm. Code 926 is not a market conduct action for purposes of |
| 17 | | this Section; however, the Department may initiate market |
| 18 | | conduct actions based on information gathered during that |
| 19 | | process. "Market conduct action" includes: |
| 20 | | (1) correspondence with the company or person; |
| 21 | | (2) interviews with the company or person; |
| 22 | | (3) information gathering; |
| 23 | | (4) policy and procedure reviews; |
| 24 | | (5) interrogatories; |
| 25 | | (6) review of company or person self-evaluations and |
| 26 | | voluntary compliance programs; |
|
| | HB3799 Engrossed | - 3 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | (7) self-audits; and |
| 2 | | (8) market conduct examinations. |
| 3 | | "Market conduct examination" or "examination" means any |
| 4 | | type of examination, other than a financial examination, that |
| 5 | | assesses a regulated person's compliance with the laws, rules, |
| 6 | | and regulations applicable to the examinee. "Market conduct |
| 7 | | examination" includes comprehensive examinations, targeted |
| 8 | | examinations, and follow-up examinations, which may be |
| 9 | | conducted as desk examinations, on-site examinations, or a |
| 10 | | combination of those 2 methods. |
| 11 | | "Market conduct surveillance" means market analysis or a |
| 12 | | market conduct action. |
| 13 | | "Market conduct surveillance personnel" means those |
| 14 | | individuals employed or retained by the Department and |
| 15 | | designated by the Director to collect, analyze, review, or act |
| 16 | | on information in the insurance marketplace that identifies |
| 17 | | patterns or practices of persons subject to the Director's |
| 18 | | jurisdiction. "Market conduct surveillance personnel" includes |
| 19 | | all persons identified as an examiner in the insurance laws or |
| 20 | | rules of this State if the Director has designated them to |
| 21 | | assist her or him in ascertaining the nonfinancial business |
| 22 | | practices, performance, and operations of a company or person |
| 23 | | subject to the Director's jurisdiction. |
| 24 | | "On-site examination" means an examination conducted at |
| 25 | | the company's or person's home office or the location where |
| 26 | | the records under review are stored. |
|
| | HB3799 Engrossed | - 4 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | "SOFR rate" means the Secured Overnight Financing Rate |
| 2 | | published by the Federal Reserve Bank of New York every |
| 3 | | business day. |
| 4 | | (b) Companies and persons subject to surveillance. The |
| 5 | | Director, for the purposes of ascertaining the nonfinancial |
| 6 | | business practices, performance, and operations of any person |
| 7 | | subject to the Director's jurisdiction or within the |
| 8 | | marketplace, may engage in market conduct actions or market |
| 9 | | analysis relating to: |
| 10 | | (1) any company transacting or being organized to |
| 11 | | transact business in this State; |
| 12 | | (2) any person engaged in or proposing to be engaged |
| 13 | | in the organization, promotion, or solicitation of shares |
| 14 | | or capital contributions to or aiding in the formation of |
| 15 | | a company; |
| 16 | | (3) any person having a written or oral contract |
| 17 | | pertaining to the management or control of a company as |
| 18 | | general agent, managing agent, or attorney-in-fact; |
| 19 | | (4) any licensed or registered producer, firm, |
| 20 | | pharmacy benefit manager, administrator, or any person |
| 21 | | making application for any license, certificate, or |
| 22 | | registration; |
| 23 | | (5) any person engaged in the business of adjusting |
| 24 | | losses or financing premiums; or |
| 25 | | (6) any person, organization, trust, or corporation |
| 26 | | having custody or control of information reasonably |
|
| | HB3799 Engrossed | - 5 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | related to the operation, performance, or conduct of a |
| 2 | | company or person subject to the Director's jurisdiction, |
| 3 | | but only as to the operation, performance, or conduct of a |
| 4 | | company or person subject to the Director's jurisdiction. |
| 5 | | (c) Market analysis and market conduct actions. |
| 6 | | (1) The Director may perform market analysis by |
| 7 | | gathering and analyzing information from data currently |
| 8 | | available to the Director, information from surveys, data |
| 9 | | call responses, or reports that are submitted to the |
| 10 | | Director, information collected by the NAIC, and |
| 11 | | information from a variety of other sources to develop a |
| 12 | | baseline understanding of the marketplace and to identify |
| 13 | | for further review companies or practices that deviate |
| 14 | | from the norm or that may pose a potential risk to |
| 15 | | insurance consumers. The Director shall use the most |
| 16 | | recent NAIC Market Regulation Handbook as a guide in |
| 17 | | performing market analysis. The Director may also employ |
| 18 | | other guidelines or procedures as the Director may deem |
| 19 | | appropriate. |
| 20 | | (2) The Director may initiate a market conduct action |
| 21 | | subject to the following: |
| 22 | | (A) If the Director determines that further |
| 23 | | inquiry into a particular person or practice is |
| 24 | | needed, then the Director may consider undertaking a |
| 25 | | market conduct action. The Director shall inform the |
| 26 | | examinee of the initiation of the market conduct |
|
| | HB3799 Engrossed | - 6 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | action and shall use the most recent NAIC Market |
| 2 | | Regulation Handbook as a guide in performing the |
| 3 | | market conduct action. The Director may also employ |
| 4 | | other guidelines or procedures as the Director may |
| 5 | | deem appropriate. |
| 6 | | (B) For an examination, the Director shall conduct |
| 7 | | a pre-examination conference with the examinee to |
| 8 | | clarify expectations before commencement of the |
| 9 | | examination. At the pre-examination conference, the |
| 10 | | Director or the market conduct surveillance personnel |
| 11 | | shall disclose the basis of the examination, including |
| 12 | | the statutes, regulations, or business practices at |
| 13 | | issue. The Director shall provide at least 30 days' |
| 14 | | advance notice of the date of the pre-examination |
| 15 | | conference unless circumstances warrant that the |
| 16 | | examination proceed more quickly. |
| 17 | | (C) The Director may coordinate a market conduct |
| 18 | | action and findings of this State with market conduct |
| 19 | | actions and findings of other states. |
| 20 | | (3) Nothing in this Section requires the Director to |
| 21 | | undertake market analysis before initiating any market |
| 22 | | conduct action. |
| 23 | | (4) Nothing in this Section restricts the Director to |
| 24 | | the type of market conduct action he or she initially |
| 25 | | selected. |
| 26 | | (5) A regulated person is required to respond to a |
|
| | HB3799 Engrossed | - 7 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | market analysis data call or to an information request in |
| 2 | | a market conduct action on the terms and conditions |
| 3 | | established by the Director. The Department shall |
| 4 | | establish reasonable timelines that are commensurate with |
| 5 | | the volume and nature of the data required to be collected |
| 6 | | in the information request. |
| 7 | | (6) Without limiting the contents of any examination |
| 8 | | report, market conduct actions taken as a result of a |
| 9 | | market analysis shall focus primarily on the general |
| 10 | | business practices and compliance activities of companies |
| 11 | | or persons rather than identifying infrequent or |
| 12 | | unintentional random errors that do not cause significant |
| 13 | | consumer harm. The Director may give a company or person |
| 14 | | an opportunity to resolve matters that are identified as a |
| 15 | | result of a market analysis to the Director's satisfaction |
| 16 | | before undertaking a market conduct action against the |
| 17 | | company or person. |
| 18 | | (d) Access to books and records. Every examinee and its |
| 19 | | officers, directors, and agents must provide to the Director |
| 20 | | convenient and free access at all reasonable hours at its |
| 21 | | office or location to all books, records, and documents and |
| 22 | | any or all papers relating to the business, performance, |
| 23 | | operations, and affairs of the examinee or its affiliates. The |
| 24 | | officers, directors, and agents of the examinee must |
| 25 | | facilitate the market conduct action and aid in the action so |
| 26 | | far as it is in their power to do so. The Director and any |
|
| | HB3799 Engrossed | - 8 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | authorized market conduct surveillance personnel have the |
| 2 | | power to administer oaths and examine under oath any person |
| 3 | | relevant to the business of the examinee. A failure to produce |
| 4 | | requested books, records, or documents by the deadline shall |
| 5 | | not be a violation until after the later of: |
| 6 | | (1) 5 business days after the initial response |
| 7 | | deadline set by the Director or authorized personnel; or |
| 8 | | (2) an extended deadline granted by the Director or |
| 9 | | authorized personnel. |
| 10 | | (e) Examination report. The market conduct surveillance |
| 11 | | personnel designated by the Director under Section 402 must |
| 12 | | make a full and true report of every examination made by them |
| 13 | | that contains only facts ascertained from the books, papers, |
| 14 | | records, documents, and other evidence obtained by |
| 15 | | investigation and examined by them or ascertained from the |
| 16 | | testimony of officers, agents, or other persons examined under |
| 17 | | oath concerning the business, affairs, conduct, and |
| 18 | | performance of the examinee. The report of examination must be |
| 19 | | verified by the oath of the examiner in charge thereof, and |
| 20 | | when so verified is prima facie evidence in any action or |
| 21 | | proceeding in the name of the State against the examinee, its |
| 22 | | officers, directors, or agents upon the facts stated therein. |
| 23 | | (f) Examinee response to examination report. The |
| 24 | | Department and the examinee shall comply with the following |
| 25 | | timeline, unless a mutual agreement is reached to modify the |
| 26 | | timeline: |
|
| | HB3799 Engrossed | - 9 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | (1) The Department shall deliver a draft report to the |
| 2 | | examinee as soon as reasonably practicable. Nothing in |
| 3 | | this Section prevents the Department from sharing an |
| 4 | | earlier draft of the report with the examinee before |
| 5 | | confirming that the examination is completed. |
| 6 | | (2) If the examinee chooses to respond with written |
| 7 | | submissions or rebuttals, then the examinee must do so |
| 8 | | within 30 days after receipt of any draft report delivered |
| 9 | | after the completion of the examination. |
| 10 | | (3) As soon as reasonably practicable after receipt of |
| 11 | | any written submissions or rebuttals, the Department shall |
| 12 | | issue a final report. Whenever the Department has made |
| 13 | | substantive changes to a previously shared draft report, |
| 14 | | unless those changes remove part or all of an alleged |
| 15 | | violation or were proposed by the examinee, the Department |
| 16 | | shall deliver the revised version to the examinee as a new |
| 17 | | draft and shall allow the examinee 30 days to respond |
| 18 | | before the Department issues a final report. |
| 19 | | (4) The examinee shall, within 10 days after the |
| 20 | | issuance of the final report, accept the final report or |
| 21 | | request a hearing in writing, unless granted an extension |
| 22 | | by mutual agreement. Failure to take either action within |
| 23 | | 10 days or the mutually agreed extension shall be deemed |
| 24 | | an acceptance of the final report. If the examinee accepts |
| 25 | | the examination report, the Director shall continue to |
| 26 | | hold the content of the examination report as private and |
|
| | HB3799 Engrossed | - 10 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | confidential for a period of 30 days. Thereafter, the |
| 2 | | Director shall open the final report for public |
| 3 | | inspection. |
| 4 | | (g) Hearing; final examination report. Notwithstanding |
| 5 | | anything to the contrary in this Code or Department rules, if |
| 6 | | the examinee requests a hearing, then the following procedures |
| 7 | | apply: |
| 8 | | (1) The examinee must request the hearing in writing |
| 9 | | and must specify the issues in the final report that the |
| 10 | | examinee is challenging. The examinee is limited to |
| 11 | | challenging the issues that were previously challenged in |
| 12 | | the examinee's written submission and rebuttal or |
| 13 | | supplemental submission and rebuttal pursuant to |
| 14 | | paragraphs (2) and (3) of subsection (f). |
| 15 | | (2) Except as permitted in paragraphs (3) and (8) of |
| 16 | | this subsection, the hearing shall be limited to the |
| 17 | | written arguments submitted by the parties to the |
| 18 | | designated hearing officer. The designated hearing officer |
| 19 | | may, however, grant a live hearing upon the request of |
| 20 | | either party. |
| 21 | | (3) Discovery is limited to the market conduct |
| 22 | | surveillance personnel's work papers that are relevant to |
| 23 | | the issues the examinee is challenging. The relevant |
| 24 | | market conduct surveillance personnel's work papers shall |
| 25 | | be admitted into the record. No other forms of discovery, |
| 26 | | including depositions and interrogatories, are allowed, |
|
| | HB3799 Engrossed | - 11 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | except upon written agreement of the examinee and the |
| 2 | | Department when necessary to conduct a fair hearing or as |
| 3 | | otherwise provided in this subsection. |
| 4 | | (4) Only the examinee and the Department may submit |
| 5 | | written arguments. |
| 6 | | (5) The examinee must submit its written argument and |
| 7 | | any supporting evidence within 30 days after the |
| 8 | | Department serves a formal notice of hearing. |
| 9 | | (6) The Department must submit its written response |
| 10 | | and any supporting evidence within 30 days after the |
| 11 | | examinee submits its written argument. |
| 12 | | (7) The designated hearing officer may allow |
| 13 | | additional written submissions if necessary or useful to |
| 14 | | the fair resolution of the hearing. |
| 15 | | (8) If either the examinee or the Department submit |
| 16 | | written testimony or affidavits, then the opposing party |
| 17 | | shall be given the opportunity to cross-examine the |
| 18 | | witness and to submit the cross-examination to the hearing |
| 19 | | officer before a decision. |
| 20 | | (9) The Director shall issue a decision accompanied by |
| 21 | | findings and conclusions. The Director's order is a final |
| 22 | | administrative decision and shall be served upon the |
| 23 | | examinee together with a copy of the final report within |
| 24 | | 90 days after the conclusion of the hearing. The hearing |
| 25 | | is deemed concluded on the later of the last date of any |
| 26 | | live hearing or the final deadline date for written |
|
| | HB3799 Engrossed | - 12 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | submissions to the hearing officer, including any |
| 2 | | continuances or supplemental briefings permitted by the |
| 3 | | hearing officer. |
| 4 | | (10) Any portion of the final examination report that |
| 5 | | was not challenged by the examinee is incorporated into |
| 6 | | the decision of the Director. |
| 7 | | (11) Findings of fact and conclusions of law in the |
| 8 | | Director's final administrative decision are prima facie |
| 9 | | evidence in any legal or regulatory action. |
| 10 | | (12) If an examinee has requested a hearing, then the |
| 11 | | Director shall continue to hold the final report and any |
| 12 | | related decision as private and confidential for a period |
| 13 | | of 49 days after the final administrative decision. After |
| 14 | | the 49-day period expires, the Director shall open the |
| 15 | | final report and any related decision for public |
| 16 | | inspection if a court of competent jurisdiction has not |
| 17 | | stayed its publication. |
| 18 | | (h) Disclosure. So long as the recipient agrees to and |
| 19 | | verifies in writing its legal authority to hold the |
| 20 | | information confidential in a manner consistent with this |
| 21 | | Section, nothing in this Section prevents the Director from |
| 22 | | disclosing at any time the content of an examination report, |
| 23 | | preliminary examination report, or results, or any matter |
| 24 | | relating to a report or results, to: |
| 25 | | (1) the insurance regulatory authorities of any other |
| 26 | | state; or |
|
| | HB3799 Engrossed | - 13 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | (2) any agency or office of the federal government. |
| 2 | | (i) Confidentiality. |
| 3 | | (1) The Director and any other person in the course of |
| 4 | | market conduct surveillance shall keep confidential all |
| 5 | | documents, including working papers, third-party models, |
| 6 | | or products; complaint logs; copies of any documents |
| 7 | | created, produced, obtained by, or disclosed to the |
| 8 | | Director, market conduct surveillance personnel, or any |
| 9 | | other person in the course of market conduct surveillance |
| 10 | | conducted pursuant to this Section; and all documents |
| 11 | | obtained by the NAIC pursuant to this Section. The |
| 12 | | documents shall remain confidential after the termination |
| 13 | | of the market conduct surveillance, are not subject to |
| 14 | | subpoena, are not subject to discovery or admissible as |
| 15 | | evidence in private civil litigation, are not subject to |
| 16 | | disclosure under the Freedom of Information Act, and must |
| 17 | | not be made public at any time or used by the Director or |
| 18 | | any other person, except as provided in paragraphs (3), |
| 19 | | (4), and (6) of this subsection (i) and in subsection (k). |
| 20 | | (2) The Director and any other person in the course of |
| 21 | | market conduct surveillance shall keep confidential any |
| 22 | | self-evaluation or voluntary compliance program documents |
| 23 | | disclosed to the Director or other person by an examinee |
| 24 | | and the data collected via the NAIC market conduct annual |
| 25 | | statement. The documents are not subject to subpoena, are |
| 26 | | not subject to discovery or admissible as evidence in |
|
| | HB3799 Engrossed | - 14 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | private civil litigation, are not subject to disclosure |
| 2 | | under the Freedom of Information Act, and they shall not |
| 3 | | be made public or used by the Director or any other person, |
| 4 | | except as provided in paragraphs (3) and (4) of this |
| 5 | | subsection (i), in subsection (k), or in Section 155.35. |
| 6 | | Nothing in this Section shall supersede the restrictions |
| 7 | | on disclosure under Section 155.35. |
| 8 | | (3) Notwithstanding paragraphs (1) and (2) of this |
| 9 | | subsection (i), and consistent with paragraph (5) of this |
| 10 | | subsection (i), in order to assist in the performance of |
| 11 | | the Director's duties, the Director may: |
| 12 | | (A) share documents, materials, communications, or |
| 13 | | other information, including the confidential and |
| 14 | | privileged documents, materials, or information |
| 15 | | described in this subsection (i), with other State, |
| 16 | | federal, alien, and international regulatory agencies |
| 17 | | and law enforcement authorities and the NAIC, its |
| 18 | | affiliates, and subsidiaries, if the recipient agrees |
| 19 | | to and verifies in writing its legal authority to |
| 20 | | maintain the confidentiality and privileged status of |
| 21 | | the document, material, communication, or other |
| 22 | | information; |
| 23 | | (B) receive documents, materials, communications, |
| 24 | | or information, including otherwise confidential and |
| 25 | | privileged documents, materials, or information, from |
| 26 | | the NAIC and its affiliates or subsidiaries, and from |
|
| | HB3799 Engrossed | - 15 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | regulatory and law enforcement officials of other |
| 2 | | State, federal, alien, or international jurisdictions, |
| 3 | | authorities, and agencies, and shall maintain as |
| 4 | | confidential or privileged any document, material, |
| 5 | | communication, or information received with notice or |
| 6 | | the understanding that it is confidential or |
| 7 | | privileged under the laws of the jurisdiction that is |
| 8 | | the source of the document, material, communication, |
| 9 | | or information; and |
| 10 | | (C) enter into agreements governing the sharing |
| 11 | | and use of information consistent with this Section. |
| 12 | | (4) Nothing in this Section limits: |
| 13 | | (A) the Director's authority to use, if consistent |
| 14 | | with subsection (5) of Section 188.1, as applicable, |
| 15 | | any final or preliminary examination report, any |
| 16 | | market conduct surveillance or examinee work papers or |
| 17 | | other documents, or any other information discovered |
| 18 | | or developed during the course of any market conduct |
| 19 | | surveillance in the furtherance of any legal or |
| 20 | | regulatory action initiated by the Director that the |
| 21 | | Director may, in the Director's sole discretion, deem |
| 22 | | appropriate; however, confidential or privileged |
| 23 | | information about a company or person that is used in |
| 24 | | the legal or regulatory action shall not be made |
| 25 | | public except by order of a court of competent |
| 26 | | jurisdiction or with the written consent of the |
|
| | HB3799 Engrossed | - 16 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | company or person; or |
| 2 | | (B) the ability of an examinee to conduct |
| 3 | | discovery in accordance with paragraph (3) of |
| 4 | | subsection (g). |
| 5 | | (5) Disclosure to or by the Director of documents, |
| 6 | | materials, communications, or information required as part |
| 7 | | of any type of market conduct surveillance does not waive |
| 8 | | any applicable privilege or claim of confidentiality in |
| 9 | | the documents, materials, communications, or information. |
| 10 | | (6) Notwithstanding the confidentiality requirements |
| 11 | | of this Section or otherwise imposed by State law, if the |
| 12 | | Director performs a data call, other than the collection |
| 13 | | of data for the NAIC market conduct annual statement, the |
| 14 | | Director may make the results of the data call available |
| 15 | | for public inspection in an aggregated format that does |
| 16 | | not disclose information or data attributed to any |
| 17 | | specific company or person, including the name of any |
| 18 | | company or person who responded to the data call, so long |
| 19 | | as the Director provides all companies or persons that |
| 20 | | responded to the data call 15 days' notice identifying the |
| 21 | | information to be publicly released. Nothing in this |
| 22 | | Section requires the Director to publish results from any |
| 23 | | data call. A data call does not need a warrant or a final |
| 24 | | report. Failure to comply with a data call may result in a |
| 25 | | fine up to $10,000 per day per offense. |
| 26 | | (j) Corrective actions. |
|
| | HB3799 Engrossed | - 17 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | (1) As a result of any market conduct action, the |
| 2 | | Director may take any action the Director considers |
| 3 | | necessary or appropriate in accordance with the report of |
| 4 | | examination or any hearing thereon for acts in violation |
| 5 | | of any law, rule, or prior lawful order of the Director. No |
| 6 | | corrective action, including a penalty, shall be ordered |
| 7 | | with respect to violations in transactions with consumers |
| 8 | | or other entities that are isolated occurrences or that |
| 9 | | occur with such low frequency as to fall below a |
| 10 | | reasonable margin of error. Such actions include, but are |
| 11 | | not limited to: |
| 12 | | (A) requiring the regulated person to undertake |
| 13 | | corrective actions to cease and desist an identified |
| 14 | | violation or institute processes and practices to |
| 15 | | comply with applicable standards; |
| 16 | | (B) requiring reimbursement or restitution of any |
| 17 | | actual losses or damages to persons harmed by the |
| 18 | | regulated person's violation with interest from the |
| 19 | | date that the actual loss or damage was incurred, |
| 20 | | which shall be calculated at the SOFR rate applicable |
| 21 | | on the date that the actual loss or damage was incurred |
| 22 | | plus 2%; and |
| 23 | | (C) imposing civil penalties as provided in this |
| 24 | | subsection (j). |
| 25 | | (2) The Director may order a penalty of up to $2,000 |
| 26 | | for each violation of any law, rule, or prior lawful order |
|
| | HB3799 Engrossed | - 18 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | of the Director. Any failure to respond to an information |
| 2 | | request in a market conduct action or violation of |
| 3 | | subsection (d) may carry a fine of up to $10,000 per day |
| 4 | | per offense $1,000 per day up to a maximum of $50,000. The |
| 5 | | penalty shall be paid into the Insurance Producer |
| 6 | | Administration Fund. Fines and penalties shall be |
| 7 | | consistent, reasonable, and justifiable, and the Director |
| 8 | | may consider reasonable criteria in ordering the fines and |
| 9 | | penalties, including, but not limited to, consumer harm, |
| 10 | | the intentionality of any violations, or remedial actions |
| 11 | | already undertaken by the examinee. The Director shall |
| 12 | | communicate to the examinee the basis for any assessed |
| 13 | | fine or penalty. |
| 14 | | (3) If any other provision of this Code or any other |
| 15 | | law or rule under the Director's jurisdiction prescribes |
| 16 | | an amount or range of monetary penalty for a violation of a |
| 17 | | particular statute or rule or a maximum penalty in the |
| 18 | | aggregate for repeated violations, the Director shall |
| 19 | | assess penalties pursuant to the terms of the statute or |
| 20 | | rule allowing the largest penalty. |
| 21 | | (4) If any other provision of this Code or any other |
| 22 | | law or rule under the Director's jurisdiction prescribes |
| 23 | | or specifies a method by which the Director is to |
| 24 | | determine a violation, then compliance with the process |
| 25 | | set forth herein shall be deemed to comply with the method |
| 26 | | prescribed or specified in the other provision. |
|
| | HB3799 Engrossed | - 19 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | (5) If the Director imposes any sanctions or |
| 2 | | corrective actions described in subparagraphs (A) through |
| 3 | | (C) of paragraph (1) of this subsection (j) based on the |
| 4 | | final report, the Director shall include those actions in |
| 5 | | a proposed stipulation and consent order enclosed with the |
| 6 | | final report issued to the examinee under subsection (f). |
| 7 | | The examinee shall have 10 days to sign the order or |
| 8 | | request a hearing in writing on the actions proposed in |
| 9 | | the order regardless of whether the examinee requests a |
| 10 | | hearing on the contents of the report under subsection |
| 11 | | (f). If the examinee does not sign the order or request a |
| 12 | | hearing on the proposed actions or the final report within |
| 13 | | 10 days, the Director may issue a final order imposing the |
| 14 | | sanctions or corrective actions. Nothing in this Section |
| 15 | | prevents the Department from sharing an earlier draft of |
| 16 | | the proposed order with the examinee before issuing the |
| 17 | | final report. |
| 18 | | (6) If the examinee accepts the order and the final |
| 19 | | report, the Director shall hold the content of the order |
| 20 | | and report as private and confidential for a period of 30 |
| 21 | | days. Thereafter, the Director shall open the order and |
| 22 | | report for public inspection. |
| 23 | | (7) If the examinee makes a timely request for a |
| 24 | | hearing on the order, the request must specify the |
| 25 | | sanctions or corrective actions in the order that the |
| 26 | | examinee is challenging. Any hearing shall follow the |
|
| | HB3799 Engrossed | - 20 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | procedures set forth in paragraphs (2) through (7) of |
| 2 | | subsection (g). |
| 3 | | (8) If the examinee has also requested a hearing on |
| 4 | | the contents of the report, then that hearing shall be |
| 5 | | consolidated with the hearing on the order. The Director |
| 6 | | shall not impose sanctions or corrective actions under |
| 7 | | this Section until the conclusion of the hearing. |
| 8 | | (9) The Director shall issue a decision accompanied by |
| 9 | | findings and conclusions along with any corrective actions |
| 10 | | or sanctions. Any sanctions or corrective actions shall be |
| 11 | | based on the final report accepted by the examinee or |
| 12 | | adopted by the Director under paragraph (9) of subsection |
| 13 | | (g). The Director's order is a final administrative |
| 14 | | decision and shall be served upon the examinee together |
| 15 | | with a copy of the final report within 90 days after the |
| 16 | | conclusion of the hearing or within 10 days after the |
| 17 | | examinee's acceptance of the proposed order and final |
| 18 | | report, as applicable. The hearing is deemed concluded on |
| 19 | | the later of the last date of any live hearing or the final |
| 20 | | deadline date for written submissions to the hearing |
| 21 | | officer, including any continuances or supplemental |
| 22 | | briefings permitted by the hearing officer. |
| 23 | | (10) If an examinee has requested a hearing under this |
| 24 | | subsection (i), the Director shall continue to hold the |
| 25 | | final order and examination report as private and |
| 26 | | confidential for a period of 49 days after the final |
|
| | HB3799 Engrossed | - 21 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | administrative decision. After the 49-day period expires, |
| 2 | | the Director shall open the final order and examination |
| 3 | | report if a court of competent jurisdiction has not stayed |
| 4 | | their publication. |
| 5 | | (k) National market conduct databases. The Director shall |
| 6 | | collect and report market data to the NAIC's market |
| 7 | | information systems, including, but not limited to, the |
| 8 | | Complaint Database System, the Examination Tracking System, |
| 9 | | and the Regulatory Information Retrieval System, or other |
| 10 | | successor NAIC products as determined by the Director. |
| 11 | | Information collected and maintained by the Department for |
| 12 | | inclusion in these NAIC market information systems shall be |
| 13 | | compiled in a manner that meets the requirements of the NAIC. |
| 14 | | Confidential or privileged information collected, reported, or |
| 15 | | maintained under this subsection (k) shall be subject to the |
| 16 | | protections and restrictions on disclosure in subsection (i). |
| 17 | | (l) Immunity of market conduct surveillance personnel. |
| 18 | | (1) No cause of action shall arise nor shall any |
| 19 | | liability be imposed against the Director, the Director's |
| 20 | | authorized representatives, market conduct surveillance |
| 21 | | personnel, or an examiner appointed by the Director for |
| 22 | | any statements made or conduct performed in good faith |
| 23 | | while carrying out the provisions of this Section. |
| 24 | | (2) No cause of action shall arise nor shall any |
| 25 | | liability be imposed against any person for the act of |
| 26 | | communicating or delivering information or data to the |
|
| | HB3799 Engrossed | - 22 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | Director, the Director's authorized representative, market |
| 2 | | conduct surveillance personnel, or examiner pursuant to an |
| 3 | | examination made under this Section, if the act of |
| 4 | | communication or delivery was performed in good faith and |
| 5 | | without fraudulent intent or the intent to deceive. |
| 6 | | (3) A person identified in paragraph (1) of this |
| 7 | | subsection (l) shall be entitled to an award of attorney's |
| 8 | | fees and costs if he or she is the prevailing party in a |
| 9 | | civil cause of action for libel, slander, or any other |
| 10 | | relevant tort arising out of activities in carrying out |
| 11 | | the provisions of this Section and the party bringing the |
| 12 | | action was not substantially justified in doing so. As |
| 13 | | used in this paragraph, a proceeding is substantially |
| 14 | | justified if it had a reasonable basis in law or fact at |
| 15 | | the time it was initiated. |
| 16 | | (4) This subsection (l) does not abrogate or modify in |
| 17 | | any way any common law or statutory privilege or immunity |
| 18 | | heretofore enjoyed by any person identified in paragraph |
| 19 | | (1) of this subsection (l). |
| 20 | | (Source: P.A. 103-897, eff. 1-1-25.) |
| 21 | | (215 ILCS 5/132.3) (from Ch. 73, par. 744.3) |
| 22 | | Sec. 132.3. Authority, scope, and scheduling of |
| 23 | | examinations. |
| 24 | | (a) The Director or any of his examiners may conduct an |
| 25 | | examination of any company as often as the Director, in his |
|
| | HB3799 Engrossed | - 23 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | sole discretion, deems appropriate, but shall, at a minimum, |
| 2 | | conduct an examination of every insurer authorized or licensed |
| 3 | | in this State not less frequently than once every 5 years. In |
| 4 | | scheduling and determining the nature, scope, and frequency of |
| 5 | | the examinations, the Director shall consider the results of |
| 6 | | financial statement analyses and ratios, changes in management |
| 7 | | or ownership, actuarial opinions, reports of independent |
| 8 | | certified public accountants and other criteria set forth in |
| 9 | | the Examiners' Handbook adopted by the National Association of |
| 10 | | Insurance Commissioners and in effect when the Director |
| 11 | | exercises discretion under this subsection. |
| 12 | | (b) For purposes of completing an examination of any |
| 13 | | company, the Director may examine or investigate any person, |
| 14 | | or the business of any person, insofar as the examination or |
| 15 | | investigation is, in the sole discretion of the Director, |
| 16 | | necessary or material to the examination of the company. |
| 17 | | (b-5) The Director may issue a data call to any company to |
| 18 | | collect any information within that company or its affiliate's |
| 19 | | control. If an insurer fails to comply with the data call, the |
| 20 | | Director may assess a fine up to $10,000 per day per offense. A |
| 21 | | data call does not require an examination warrant or a final |
| 22 | | report. Any information provided through a data call shall be |
| 23 | | treated as confidential and privileged. The information shall |
| 24 | | not be subject to subpoena or discovery and shall not be |
| 25 | | admissible into evidence in any private civil action. No |
| 26 | | waiver of privilege or confidentiality shall occur as a result |
|
| | HB3799 Engrossed | - 24 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | of responding to such data call. |
| 2 | | (c) In lieu of an examination of any foreign or alien |
| 3 | | insurer authorized or licensed in this State, the Director may |
| 4 | | accept an examination report on the company as prepared by the |
| 5 | | insurance department for the company's state of domicile or |
| 6 | | port-of-entry state until January 1, 1994. Thereafter, those |
| 7 | | reports may only be accepted if (1) the insurance department |
| 8 | | was at the time of the examination accredited under the |
| 9 | | National Association of Insurance Commissioners' Financial |
| 10 | | Regulation Standards and Accreditation Program, (2) the |
| 11 | | examination is performed under the supervision of an |
| 12 | | accredited insurance department or with the participation of |
| 13 | | one or more examiners who are employed by an accredited state |
| 14 | | insurance department, and who, after a review of the |
| 15 | | examination work papers and report, state under oath that the |
| 16 | | examination was performed in a manner consistent with the |
| 17 | | standards and procedures required by their insurance |
| 18 | | department, or (3) the Director otherwise determines that the |
| 19 | | examination was performed in a manner substantially similar to |
| 20 | | the standards and procedures required by Sections 132.1 |
| 21 | | through 132.6 of this Code. |
| 22 | | (d) Any company that or person who violates or aids and |
| 23 | | abets any violation of a written order issued under this |
| 24 | | Section is guilty of a business offense and may be fined up to |
| 25 | | $10,000 per day per offense. The penalty shall be paid into the |
| 26 | | Insurance Producer Administration Fund. |
|
| | HB3799 Engrossed | - 25 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | (Source: P.A. 89-97, eff. 7-7-95.) |
| 2 | | (215 ILCS 5/143.15) (from Ch. 73, par. 755.15) |
| 3 | | Sec. 143.15. Mailing of cancellation notice. All notices |
| 4 | | of cancellation of insurance as defined in subsections (a), |
| 5 | | (b) and (c) of Section 143.13 must be mailed at least 30 days |
| 6 | | prior to the effective date of cancellation to the named |
| 7 | | insured if the effective date of cancellation is within the |
| 8 | | first 60 days of coverage. After the coverage has been |
| 9 | | effective for 61 days or more, all notices must be mailed at |
| 10 | | least 60 days prior to the effective date of cancellation. |
| 11 | | However ; however, if cancellation is for nonpayment of |
| 12 | | premium, the notice of cancellation must be mailed at least 10 |
| 13 | | days before the effective date of the cancellation to the last |
| 14 | | mailing address known to the company. All notices of |
| 15 | | cancellation to the named insured shall include a specific |
| 16 | | explanation of the reason or reasons for cancellation. For |
| 17 | | purposes of this Section, the mortgagee or lien holder, if |
| 18 | | known, may opt to accept notification electronically. |
| 19 | | (Source: P.A. 100-475, eff. 1-1-18.) |
| 20 | | (215 ILCS 5/143.17) (from Ch. 73, par. 755.17) |
| 21 | | Sec. 143.17. Notice of intention not to renew. |
| 22 | | a. No company shall fail to renew any policy of insurance, |
| 23 | | as defined in subsections (a), (b), (c), and (h) of Section |
| 24 | | 143.13, to which Section 143.11 applies, unless it shall send |
|
| | HB3799 Engrossed | - 26 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | by mail to the named insured at least 60 30 days advance notice |
| 2 | | of its intention not to renew. The company shall maintain |
| 3 | | proof of mailing of such notice on a recognized U.S. Post |
| 4 | | Office form or a form acceptable to the U. S. Post Office or |
| 5 | | other commercial mail delivery service. The nonrenewal shall |
| 6 | | not become effective until at least 60 30 days from the proof |
| 7 | | of mailing date of the notice to the name insured. |
| 8 | | Notification shall also be sent to the insured's broker, if |
| 9 | | known, or the agent of record, if known, and to the last known |
| 10 | | mortgagee or lien holder. For purposes of this Section, the |
| 11 | | mortgagee or lien holder, insured's broker, or the agent of |
| 12 | | record may opt to accept notification electronically. However, |
| 13 | | where cancellation is for nonpayment of premium, the notice of |
| 14 | | cancellation must be mailed at least 10 days before the |
| 15 | | effective date of the cancellation. |
| 16 | | b. This Section does not apply if the company has |
| 17 | | manifested its willingness to renew directly to the named |
| 18 | | insured. Such written notice shall specify the premium amount |
| 19 | | payable, including any premium payment plan available, and the |
| 20 | | name of any person or persons, if any, authorized to receive |
| 21 | | payment on behalf of the company. If no person is so |
| 22 | | authorized, the premium notice shall so state. |
| 23 | | b-5. This Section does not apply if the company manifested |
| 24 | | its willingness to renew directly to the named insured. |
| 25 | | However, no company may impose changes in deductibles or |
| 26 | | coverage for any policy forms applicable to an entire line of |
|
| | HB3799 Engrossed | - 27 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | business enumerated in subsections (a), (b), (c), and (h) of |
| 2 | | Section 143.13 to which Section 143.11 applies unless the |
| 3 | | company mails to the named insured written notice of the |
| 4 | | change in deductible or coverage at least 60 days prior to the |
| 5 | | renewal or anniversary date. Notice shall also be sent to the |
| 6 | | insured's broker, if known, or the agent of record. |
| 7 | | c. Should a company fail to comply with (a) or (b) of this |
| 8 | | Section, the policy shall terminate only on the effective date |
| 9 | | of any similar insurance procured by the insured with respect |
| 10 | | to the same subject or location designated in both policies. |
| 11 | | d. Renewal of a policy does not constitute a waiver or |
| 12 | | estoppel with respect to grounds for cancellation which |
| 13 | | existed before the effective date of such renewal. |
| 14 | | e. In all notices of intention not to renew any policy of |
| 15 | | insurance, as defined in Section 143.11 the company shall |
| 16 | | provide the named insured a specific explanation of the |
| 17 | | reasons for nonrenewal. |
| 18 | | f. For purposes of this Section, the insured's broker, if |
| 19 | | known, or the agent of record and the mortgagee or lien holder |
| 20 | | may opt to accept notification electronically. |
| 21 | | (Source: P.A. 100-475, eff. 1-1-18.) |
| 22 | | (215 ILCS 5/Art. XLVIII heading new) |
| 23 | | ARTICLE XLVIII. CLIMATE RISK DISCLOSURE |
| 24 | | (215 ILCS 5/1801 new) |
|
| | HB3799 Engrossed | - 28 - | LRB104 11270 BAB 21355 b |
|
|
| 1 | | Sec. 1801. Short title. This Article may be cited as the |
| 2 | | Climate Risk Disclosure Law. |
| 3 | | (215 ILCS 5/1805 new) |
| 4 | | Sec. 1805. Purpose. The purpose of this Article is to |
| 5 | | enhance transparency about how insurers manage climate-related |
| 6 | | risks and to clarify the Department's authority to require |
| 7 | | companies to participate in climate surveys issued by entities |
| 8 | | including but not limited to the Department and the National |
| 9 | | Association of Insurance Commissioners. This Article shall be |
| 10 | | liberally interpreted to carry into effect the intent of this |
| 11 | | Section. |
| 12 | | (215 ILCS 5/1810 new) |
| 13 | | Sec. 1810. Applicability. This Article applies to all |
| 14 | | companies licensed in Illinois under Classes 2 and 3 of |
| 15 | | Section 4 of this Code that write $100,000,000 or more |
| 16 | | annually in premiums. This threshold may be altered by rule. |
| 17 | | (215 ILCS 5/1815 new) |
| 18 | | Sec. 1815. Climate disclosure survey participation. All |
| 19 | | insurers subject to this Article shall, upon direction from |
| 20 | | the Department, participate in National Association of |
| 21 | | Insurance Commissioners issued climate surveys. |